+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Antibiotics Market By Action Mechanism, By Drug Class, By Country, Industry Analysis and Forecast, 2020 - 2026

  • ID: 5241436
  • Report
  • January 2021
  • Region: Asia Pacific
  • 101 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer AG
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC (GSK)
  • Johnson and Johnson
The Asia Pacific Antibiotics Market is expected to witness market growth of 6.6% CAGR during the forecast period (2020-2026).

The antibacterial agent is another name of antibiotics that has the capability to kill or slow down bacterial growth. It is widely used for curing and preventing diseases caused by bacteria. The increasing number of patients who are suffering from infectious diseases and the evolution of the latest diagnostic devices are some of the major factors that drive the market.

The antibiotics market is growing owing to the increasing consumption of antibiotics in middle and lower-income countries, huge investments in R&D activities by pharmaceutical companies, and the increasing number of infectious diseases. Although, the development of antibiotic resistance and the rising cost of drug approval hinder the growth of the antibiotic market. On the other hand, advanced prospect molecules and the development of novel combination therapies to cure antibiotic-resistant microbial infections are estimated to propel the market and provide great opportunities for the market players.

With the increasing incidents of infectious diseases, many companies in the market are actively taking efforts for the innovation of advanced products that will propel the growth of the market. There are many infections that become resistant to antibiotics; this situation provides an opportunity for companies to develop advanced products. These advanced products increase the range of treatment by the antibiotics that further support the growth of the market. The innovation of advanced prospect molecules and development of some novel combination therapies which cure antibiotic-resistant infections are expected to support the market growth.

Based on Action Mechanism, the market is segmented into Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, and Mycolic Acid Inhibitors. Based on Drug Class, the market is segmented into Cephalosporin, Penicillin, Fluoroquinolone, Macrolides, Carbapenem, Aminoglycosides, Sulfonamides, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GlaxoSmithKline PLC (GSK), Johnson and Johnson, Merck & Co., Inc., Pfizer, Inc., Bayer AG, Novartis AG, Sanofi S.A., Abbott Laboratories, F. Hoffmann-La Roche Ltd., and Eli Lilly and Company.

Scope of the Study

Market Segments covered in the Report:

By Action Mechanism
  • Cell Wall Synthesis Inhibitors
  • Protein Synthesis Inhibitors
  • DNA Synthesis Inhibitors
  • RNA Synthesis Inhibitors,
  • Mycolic Acid Inhibitors
By Drug Class
  • Cephalosporin
  • Penicillin
  • Fluoroquinolone
  • Macrolides
  • Carbapenem
  • Aminoglycosides
  • Sulfonamides,
  • Others
By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
Companies Profiled
  • GlaxoSmithKline PLC (GSK)
  • Johnson and Johnson
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Bayer AG
  • Novartis AG
  • Sanofi S.A.
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Eli Lilly and Company
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer AG
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC (GSK)
  • Johnson and Johnson
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Antibiotics Market, by Action Mechanism
1.4.2 Asia Pacific Antibiotics Market, by Drug Class
1.4.3 Asia Pacific Antibiotics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Approvals
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct - 2020, Jul) Leading Players

Chapter 4. Asia Pacific Antibiotics Market by Action Mechanism
4.1 Asia Pacific Cell Wall Synthesis Inhibitors Market by Country
4.2 Asia Pacific Protein Synthesis Inhibitors Market by Country
4.3 Asia Pacific DNA Synthesis Inhibitors Market by Country
4.4 Asia Pacific RNA Synthesis Inhibitors Market by Country
4.5 Asia Pacific Mycolic Acid Inhibitors Market by Country

Chapter 5. Asia Pacific Antibiotics Market by Drug Class
5.1 Asia Pacific Cephalosporin Market by Country
5.2 Asia Pacific Penicillin Market by Country
5.3 Asia Pacific Fluoroquinolone Market by Country
5.4 Asia Pacific Macrolides Market by Country
5.5 Asia Pacific Carbapenem Market by Country
5.6 Asia Pacific Aminoglycosides Market by Country
5.7 Asia Pacific Sulfonamides Market by Country
5.8 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Antibiotics Market by Country
6.1 China Antibiotics Market
6.1.1 China Antibiotics Market by Action Mechanism
6.1.2 China Antibiotics Market by Drug Class
6.2 Japan Antibiotics Market
6.2.1 Japan Antibiotics Market by Action Mechanism
6.2.2 Japan Antibiotics Market by Drug Class
6.3 India Antibiotics Market
6.3.1 India Antibiotics Market by Action Mechanism
6.3.2 India Antibiotics Market by Drug Class
6.4 South Korea Antibiotics Market
6.4.1 South Korea Antibiotics Market by Action Mechanism
6.4.2 South Korea Antibiotics Market by Drug Class
6.5 Singapore Antibiotics Market
6.5.1 Singapore Antibiotics Market by Action Mechanism
6.5.2 Singapore Antibiotics Market by Drug Class
6.6 Malaysia Antibiotics Market
6.6.1 Malaysia Antibiotics Market by Action Mechanism
6.6.2 Malaysia Antibiotics Market by Drug Class
6.7 Rest of Asia Pacific Antibiotics Market
6.7.1 Rest of Asia Pacific Antibiotics Market by Action Mechanism
6.7.2 Rest of Asia Pacific Antibiotics Market by Drug Class

Chapter 7. Company Profiles
7.1 GlaxoSmithKline PLC (GSK)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 Johnson and Johnson
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental &Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.3 Merck & Co., Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.1 Recent strategies and developments:
7.3.1.1 Product Launches and Product Expansions:
7.3.1.2 Approvals:
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Recent strategies and developments:
7.4.4.1 Acquisition and Mergers:
7.4.4.2 Product Launches and Product Expansions:
7.5 Bayer AG
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 Novartis AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Recent strategies and developments:
7.6.4.1 Partnerships, Collaborations, and Agreements:
7.7 Sanofi S.A.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Acquisition and Mergers:
7.7.5.2 Partnerships, Collaborations, and Agreements:
7.8 Abbott Laboratories
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 F. Hoffmann-La Roche Ltd.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Partnerships, Collaborations, and Agreements:
7.10. Eli Lilly and Company
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expense
Note: Product cover images may vary from those shown
  • GlaxoSmithKline PLC (GSK)
  • Johnson and Johnson
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Bayer AG
  • Novartis AG
  • Sanofi S.A.
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Eli Lilly and Company
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll